When it comes to the field of oncology, no one knows it better than Mikhail Blagosklonny. He is a researcher who has made several record-breaking discoveries and improvements that have had a significant impact on the world of oncology. His developments have aided doctors all over the world, and have given them new insights that they otherwise would not have had. Through this, he has helped thousands of lives around the globe. Mikhail Blagosklonny started working in the field of oncological research soon after graduating from medical school. He began working for a company that went by the name of Ordway, which was a notable oncological research company. Mikhail Blagosklonny had an incredible career at Ordway and had notable discoveries that put the company on the map.
One of the most notable discoveries that Mikhail Blagosklonny had made while he was working on his research was outside the scope of oncology and gave an impetus to developments in the field. While he was conducting research on the kind of drugs that people were given when they had cancer, he found that one particular compound was working in a way that was not reported before. The ingredient that he discovered about was called Rapamycin and started having indications towards increasing the life expectancy of people who took it. Not many researchers focus on drugs that can improve the life expectancy of people, which is why there was very little research already on it. This gave rise to more and more doctors trying to research about other drugs that could perform in ways similar to Rapamycin.
One of the other notable things that Mikhail Blagosklonny is known for is for a publication that he started. He founded Oncotarget, a peer to peer review medical journal that touched on the latest happenings and insights into the world of oncology. People from all over the world started turning to this newsletter to stay updated. Doctors from different parts of the globe started pouring in and submitting their articles to be published in the newsletter. Oncologists also used this newsletter as a platform to share the latest techniques and developments that they were implementing, so that doctors all over the world could follow in the same way. Today, Mikhail Blagosklonny is the chief editor of the publication and oversees all of the articles that are published in the newsletter.
One of the other arrays that Mikhail Blagosklonny is known for is teaching. He is currently a professor at the Roswell Park Cancer Institute and heads the oncological department there. Students all over the country choose this institute because of the guidance that they can receive from Mikhail Blagosklonny. Mikhail Blagosklonny has helped several students who have come to this institute with the hopes of becoming a notable oncologist or oncological researcher. Mikhail Blagosklonny first started teaching soon after he passed out of medical school. This was while he was still working at Ordway. Mikhail Blagosklonny was a professor at the New York Medical School before he joined the one that he currently teaches at.